Yuexi Gu
Research Subjects
Research Interests
Yuexi Gu has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Bhawana Bissa
Autophagy, Inflammation and Metabolism Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center , Albuquerque, NM, USA
2 shared publicationsSeong Won Choi
Autophagy, Inflammation and Metabolism Center of Biochemical Research Excellence, University of New Mexico Health Sciences Center , Albuquerque, NM, USA
2 shared publications- Vojo Deretic
University of New Mexico Health Sciences Center
2 shared publications Caiyun Yang
Department of Critical Care Medicine The First People's Hospital of Changshu City, Changshu Hospital Affiliated to Soochow University Changshu China
1 shared publication- Christian Behrends
Munich Cluster for Systems Neurology (SyNergy), Medical Faculty, Ludwig-Maximilians-University München, Munich, Germany
1 shared publication - Chuan-Feng Tang
State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
1 shared publication
Latest Publications
- Open Access
- 29 October 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (21) , e70928
Inhibition of Histone Deacetylases Induces Cancer Cell Apoptosis Through the PERK Pathway of ER Stress Response
Activation of the endoplasmic reticulum (ER) stress is an adaptive response to disturbed ER homeostasis caused by the accumulation of misfolded or unfolded proteins, or an acute increase in the entry of newly synthesised or mutated proteins into the ER lumen. Overwhelmed or prolonged ER stress causes apoptotic cell death or a maladaptive state of the cell, resulting in various pathological diseases including cancer, inflammation and aging. With a screening of a chemical compound library, here we show that inhibition of histone deacetylases (HDACs) induces ER stress, along with increased retro‐translocation of misfolded proteins from the ER lumen to the cytosol for proteasomal degradation. HDAC inhibitors (HDACi) activate the PERK‐eIF2α subbranch of the unfolded protein response (UPR), whereas the IRE1α and ATF6 pathways are not affected. Inhibition of the PERK subbranch with specific siRNA or a small molecule inhibitor ameliorates HDACi‐induced apoptotic cell death. In addition, a non‐phosphorylatable mutant of eIF2α, a critical substrate that transduces the PERK‐mediated ER stress response, abolishes apoptosis induced by HDACi, but not by the DNA damage reagent doxorubicin. HDACi reduce the sizes of tumours formed from wildtype but not eIF2α S51A ‐mutant cells in a xenograft model, further demonstrating the involvement of the PERK subbranch in HDACi‐induced ER stress and cell death. Our study reveals novel effects of the well‐studied family of HDAC inhibitors, which can be explored further in clinics to treat certain types of cancer manifested with abnormal ER stress conditions.
- 29 October 2025
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 29 (21) , e70928
Open AccessInhibition of Histone Deacetylases Induces Cancer Cell Apoptosis Through the PERK Pathway of ER Stress Response
Activation of the endoplasmic reticulum (ER) stress is an adaptive response to disturbed ER homeostasis caused by the accumulation of misfolded or unfolded proteins, or an acute increase in the entry of newly synthesised or mutated proteins into the ER lumen. Overwhelmed or prolonged ER stress causes apoptotic cell death or a maladaptive state of the cell, resulting in various pathological diseases including cancer, inflammation and aging. With a screening of a chemical compound library, here we show that inhibition of histone deacetylases (HDACs) induces ER stress, along with increased retro‐translocation of misfolded proteins from the ER lumen to the cytosol for proteasomal degradation. HDAC inhibitors (HDACi) activate the PERK‐eIF2α subbranch of the unfolded protein response (UPR), whereas the IRE1α and ATF6 pathways are not affected. Inhibition of the PERK subbranch with specific siRNA or a small molecule inhibitor ameliorates HDACi‐induced apoptotic cell death. In addition, a non‐phosphorylatable mutant of eIF2α, a critical substrate that transduces the PERK‐mediated ER stress response, abolishes apoptosis induced by HDACi, but not by the DNA damage reagent doxorubicin. HDACi reduce the sizes of tumours formed from wildtype but not eIF2α S51A ‐mutant cells in a xenograft model, further demonstrating the involvement of the PERK subbranch in HDACi‐induced ER stress and cell death. Our study reveals novel effects of the well‐studied family of HDAC inhibitors, which can be explored further in clinics to treat certain types of cancer manifested with abnormal ER stress conditions.
- Open Access
- 26 August 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 83, 1175-1193
NLRP6 governs hippocampal microglial phagocytosis to resist stress-induced depressive-like behaviors in mice and the intervention effect of bezafibrate
- 26 August 2025
- Published by Elsevier in Journal of Advanced Research
- Vol. 83, 1175-1193
Open AccessNLRP6 governs hippocampal microglial phagocytosis to resist stress-induced depressive-like behaviors in mice and the intervention effect of bezafibrate
- 25 July 2020
- Published by Taylor & Francis in Autophagy
- Vol. 16 (8) , 1550-1552
AMPK is activated during lysosomal damage via a galectin-ubiquitin signal transduction system
Lysosomal damage activates AMPK, a regulator of macroautophagy/autophagy and metabolism, and elicits a strong ubiquitination response. Here we show that the cytosolic lectin LGALS9 detects lysosoma...
- 25 July 2020
- Published by Taylor & Francis in Autophagy
- Vol. 16 (8) , 1550-1552
AMPK is activated during lysosomal damage via a galectin-ubiquitin signal transduction system
Lysosomal damage activates AMPK, a regulator of macroautophagy/autophagy and metabolism, and elicits a strong ubiquitination response. Here we show that the cytosolic lectin LGALS9 detects lysosoma...
- Open Access
- 18 October 2019
- Published by Springer Nature in The EMBO Journal
- Vol. 38 (22) , e101994
Mammalian Atg8 proteins regulate lysosome and autolysosome biogenesis through SNAREs
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
- 18 October 2019
- Published by Springer Nature in The EMBO Journal
- Vol. 38 (22) , e101994
Open AccessMammalian Atg8 proteins regulate lysosome and autolysosome biogenesis through SNAREs
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.